Effects of diterpene forskolin on the release reaction and protein phosphorylation of human platelets.
The effects of diterpene forskolin on the human platelet release reaction and on platelet protein phosphorylation were studied. This drug is shown to have the same effects as other agents which increase cAMP levels, namely, it inhibits the secretory response to diverse agonists and causes changes in the phosphorylation of several specific proteins. An increase of the 32P content is seen in the MW 47 000, 24 000 and 21 000 polypeptides while a decrease is observed in the MW 41 000 and 27 000 and 20 000 species. Forskolin also inhibits the changes in protein phosphorylation pattern induced by the powerful platelet secretagogue, thrombin. Our results relate the effects of antagonists of platelet secretion such as prostaglandins more closely to changes in cAMP levels and in protein phosphorylation than to other possible effects of the receptor-ligand interaction, which is by-passed by the use of forskolin. Our results also provide additional evidence involving these changes in the mechanisms which regulate the secretory process in platelets.
D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D001798:Blood Proteins / Q000378:metabolism*; D005576:Colforsin; D000242:Cyclic AMP / Q000097:blood; D004224:Diterpenes / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008970:Molecular Weight; D010766:Phosphorylation; D012701:Serotonin / Q000378:metabolism
D001798:Blood Proteins; D004224:Diterpenes; D005576:Colforsin; D012701:Serotonin; D000242:Cyclic AMP